NEW YORK, June 21 - LumiCyte next week will announce that it has brought on Shimadzu to market and distribute its SELDI-based protein-mapping technology in Japan.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.